RFK Jr.'s peptide push narrowly gains backing from FDA advisers despite objections from scientists
Fortune's coverage of the FDA advisory committee vote features dueling perspectives from panel members: pharmacist Rita Jew of the Institute for Safe Medication Practices called the lack of clinical evidence "really alarming," while pharmacy chief David Pope argued the decision should be "in the hands of the patient, the physician and the pharmacist" — illustrating the genuine divide among health professionals reviewing the same evidence.
This is a summary. The reporting is Fortune's, and the link below goes to the original article.